AI Meets Medicine: Inside Somite’s Revolutionary Vision

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/ee/d4/19/eed41970-5001-c282-e20c-41dfed699b26/mza_10297487174693465796.jpg/600x600bb.jpg

Destroy Duchenne Podcast

20 episodes

3 days ago

A podcast telling the stories of those affected by a fatal muscle wasting disease, Duchenne muscular dystrophy (DMD), that robs children of their ability to walk by the age of 11, the ability to raise their arms by their teenage years, and eventually their lives in their early 20s. Hosted by 23 year old founder of the 501 (c)3 nonprofit organization Destroy Duchenne, Elijah Stacy, who also suffers from Duchenne muscular dystrophy. The goal of the Destroy Duchenne podcast is very simple, yet ambitious: interview every person that has a relationship to Duchenne.

Non-Profit

Business

RSS

All content for Destroy Duchenne Podcast is the property of Destroy Duchenne Podcast and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Non-Profit

Business

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/6918937/6918937-1713316447098-3a1860603dd7.jpg

AI Meets Medicine: Inside Somite’s Revolutionary Vision

Destroy Duchenne Podcast

1 hour 6 minutes 35 seconds

10 months ago

AI Meets Medicine: Inside Somite’s Revolutionary Vision

Join Elijah Stacy as he explores the groundbreaking work of Somite Therapeutics, where AI and cell therapy collide to redefine medicine. In this special episode, hear from industry trailblazers like Dr. Micha Breakstone (Chorus.ai, NeuraLight.ai), Dr. Jonny Rosenfeld (MIT FutureTech), and Dr. Kristy Brown (Solid Biosciences, Rejuvenate Bio) as they discuss Somite’s AI-powered platform, AlphaStem, and its potential to transform drug development and treat complex diseases like Duchenne Muscular Dystrophy. Discover how cutting-edge science, innovation, and a bold vision for the future of healthcare are paving the way for revolutionary breakthroughs.